m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00532)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
SMAD2
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Heterogeneous nuclear ribonucleoproteins A2/B1 (HNRNPA2B1) [READER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | HNRNPA2B1, as an m6A reader, is critical in OSCC development. Its expression is significantly associated with the prognosis of Oral Squamous Cell Carcinoma(OSCC). m6A acts as a proto-oncogene that promotes the OSCC proliferation, migration, and invasion through the EMT progression via the LINE-1/TGF-beta1/Snail/Mothers against decapentaplegic homolog 2 (SMAD2) signaling pathway. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Oral squamous cell carcinoma | ICD-11: 2B6E.0 | ||
Pathway Response | TGF-beta signaling pathway | hsa04350 | ||
In-vitro Model | SCC-4 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1684 |
CAL-27 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1107 | |
YTH domain-containing family protein 2 (YTHDF2) [READER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [2] | |||
Response Summary | YTHDF2 inhibits the migration and invasion of lung adenocarcinoma cells by regulating the FAM83D-TGFbeta1-Mothers against decapentaplegic homolog 2 (SMAD2) pathway, which will play an important role in lung cancer metastasis. | |||
Target Regulation | Down regulation | |||
Responsed Disease | Lung cancer | ICD-11: 2C25 | ||
Pathway Response | mRNA surveillance pathway | hsa03015 | ||
Cell Process | Epithelial-mesenchymal transition | |||
In-vitro Model | NCI-H1299 | Lung large cell carcinoma | Homo sapiens | CVCL_0060 |
A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
Head and neck squamous carcinoma [ICD-11: 2B6E]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | HNRNPA2B1, as an m6A reader, is critical in OSCC development. Its expression is significantly associated with the prognosis of Oral Squamous Cell Carcinoma(OSCC). m6A acts as a proto-oncogene that promotes the OSCC proliferation, migration, and invasion through the EMT progression via the LINE-1/TGF-beta1/Snail/Mothers against decapentaplegic homolog 2 (SMAD2) signaling pathway. | |||
Responsed Disease | Oral squamous cell carcinoma [ICD-11: 2B6E.0] | |||
Target Regulator | Heterogeneous nuclear ribonucleoproteins A2/B1 (HNRNPA2B1) | READER | ||
Target Regulation | Up regulation | |||
Pathway Response | TGF-beta signaling pathway | hsa04350 | ||
In-vitro Model | SCC-4 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1684 |
CAL-27 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1107 | |
Lung cancer [ICD-11: 2C25]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [2] | |||
Response Summary | YTHDF2 inhibits the migration and invasion of lung adenocarcinoma cells by regulating the FAM83D-TGFbeta1-Mothers against decapentaplegic homolog 2 (SMAD2) pathway, which will play an important role in lung cancer metastasis. | |||
Responsed Disease | Lung cancer [ICD-11: 2C25] | |||
Target Regulator | YTH domain-containing family protein 2 (YTHDF2) | READER | ||
Target Regulation | Down regulation | |||
Pathway Response | mRNA surveillance pathway | hsa03015 | ||
Cell Process | Epithelial-mesenchymal transition | |||
In-vitro Model | NCI-H1299 | Lung large cell carcinoma | Homo sapiens | CVCL_0060 |
A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
References